Patients who had positive ctDNA tests after surgery were almost twice as likely to be alive at 3 years if they received ...

Patients whose metastatic colorectal cancer has progressed following chemotherapy and who lack mutations in the RAS and BRAF ...

A common aromatic shrub that has served as traditional medicine for centuries could point the way toward innovative ...

New data from two studies presented at ASCO GI 2025 demonstrated that ctDNA testing could predict recurrence risk in ...

Barry Stein had ignored symptoms that started appearing in 1995, until he was diagnosed with stage four colorectal cancer.

Researchers investigated the factors associated with treatment delay in patients with early-onset colorectal cancers.

Scientists from the University of Sharjah have found that a naturally growing aromatic plant contains ingredients with the ...

About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of neoadjuvant pembrolizumab, new data revealed.

A new test developed in the UK can accurately predict whether high-risk patients will develop bowel cancer, also known as colorectal cancer, in the five years.

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new stu ...

Researchers have discovered how a particular protein affects the growth and spread of colon cancer in humans. The study not ...

Artemisia herba-alba shows promise in combating colorectal cancer, offering new hope through its powerful medicinal ...